Woodford Investment Management
Cell Medica gets £50 million funding
November 26, 2014Research and Development, Sales and Marketing CMD-003, Cancer, Imperial Innovations, Invesco Perpetual, Woodford Investment Management, celk medica
Cellular immunotherapy development firm Cell Medica has confirmed the completion a £50 million investment round from key backers to progress …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
